Jeena Sikho Lifecare launches nine new Ayurvedic products

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Jeena Sikho Lifecare launches nine new Ayurvedic products on August 26, 2026
  • Portfolio includes eight 500 ml Arishta liquids and one headache relief patch
  • All new products are targeted exclusively at the domestic market
  • Disclosure made under Regulation 30 of SEBI LODR Regulations
powered bylight_fuzz_icon
49274917

*this image is generated using AI for illustrative purposes only.

Jeena Sikho Lifecare Ltd announced the launch of nine new products on August 26, 2026, expanding its Ayurvedic and wellness portfolio. The company disclosed the move pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The new offerings target the domestic market and include a mix of topical patches and liquid formulations. Eight of the nine products are Arishta (fermented herbal preparations) in 500 ml volumes, while one is a headache relief patch.

Product Portfolio Expansion

The launch introduces specific therapeutic categories ranging from pain management to organ-specific care. All products are scheduled for release on August 26, 2026.

Product Name Category Volume
Headache Relief Patch Patch Not Specified
Hridya Amrit Arishta Liquid 500 ml
Manobal Vardhak Arishta Liquid 500 ml
Ojas Shakti Arishta Liquid 500 ml
Stree Shakti Arishta Liquid 500 ml
Twak Suraksha Arishta Liquid 500 ml
Vata Rakshak Arishta Liquid 500 ml
Vrik Shuddhi Arishta Liquid 500 ml
Yakrit Rakshak Arishta Liquid 500 ml

Regulatory Disclosure

The company filed the intimation with the National Stock Exchange of India Limited and BSE Limited. The disclosure references SEBI Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, and Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Manish Grover, Managing Director, signed the filing from Zirakpur, Punjab.

Historical Stock Returns for Jeena Sikho Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.52%+0.89%-9.67%-16.23%-26.61%0.0%

How is Jeena Sikho Lifecare planning to differentiate its new Arishta formulations from established competitors in the crowded Ayurvedic liquid market?

What specific marketing strategies or distribution channels will the company prioritize to drive adoption of the new headache relief patch among domestic consumers?

Will the expansion into organ-specific care categories like liver and kidney support require additional regulatory approvals or clinical trials beyond standard SEBI disclosures?

Jeena Sikho Lifecare hosts investor meet on Aug 31

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Jeena Sikho Lifecare hosts investor meet on Aug 31
  • Session runs from 3:30 pm to 5:00 pm in Mumbai
  • Part of GIA Healthcare Day event
  • No UPSI to be discussed during the interaction
  • Compliance with SEBI Regulation 30 confirmed
powered bylight_fuzz_icon
49188671

*this image is generated using AI for illustrative purposes only.

Jeena Sikho Lifecare will host a physical group meeting with investors and analysts on August 31, 2026. The company announced the engagement as part of the GIA Healthcare Day, aiming to discuss its business outlook with stakeholders.

The session is scheduled from 3:30 pm to 5:00 pm at the Jio World Convention Centre in Mumbai’s Bandra Kurla Complex. Management will lead the discussions, providing updates on the company’s operations and strategic direction.

Meeting Details

The interaction is structured as a physical group meeting under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The schedule remains indicative and may change due to unforeseen developments by the company or the organizer.

Detail Information
Date August 31, 2026
Event GIA Healthcare Day
Time 3:30 pm – 5:00 pm
Location Jio World Convention Centre, BKC
Format Physical Group Meeting

Participants interested in attending can register via the access link provided in the original intimation. The company confirmed that discussions will rely solely on publicly available documents.

Regulatory Disclosure

Jeena Sikho Lifecare stated that no unpublished price-sensitive information (UPSI) will be discussed during the interaction. This ensures compliance with market fairness norms and prevents selective disclosure of material data.

The intimation was issued by Manish Grover, Managing Director of Jeena Sikho Lifecare Limited, on August 25, 2026. The notice was simultaneously filed with the National Stock Exchange of India Limited and BSE Limited.

Historical Stock Returns for Jeena Sikho Lifecare

1 Day5 Days1 Month6 Months1 Year5 Years
-0.52%+0.89%-9.67%-16.23%-26.61%0.0%

How might Jeena Sikho Lifecare's strategic updates at the GIA Healthcare Day influence its valuation relative to other listed healthcare providers in India?

What specific operational metrics or growth targets is the management likely to highlight to justify future revenue projections?

Could the physical format of this investor meeting signal a shift in Jeena Sikho Lifecare's stakeholder engagement strategy compared to previous virtual interactions?

More News on Jeena Sikho Lifecare

1 Year Returns:-26.61%